Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 45 | 2024 | 1180 | 11.160 |
Why?
|
| Heart-Assist Devices | 40 | 2024 | 756 | 10.880 |
Why?
|
| Hemodynamics | 20 | 2024 | 729 | 3.790 |
Why?
|
| Aortic Valve Insufficiency | 10 | 2024 | 132 | 3.580 |
Why?
|
| Shock, Cardiogenic | 8 | 2024 | 106 | 2.640 |
Why?
|
| Heart Transplantation | 11 | 2024 | 716 | 2.040 |
Why?
|
| Heart Ventricles | 11 | 2023 | 779 | 1.910 |
Why?
|
| Echocardiography, Doppler | 7 | 2020 | 186 | 1.810 |
Why?
|
| Ventricular Function, Left | 9 | 2024 | 603 | 1.620 |
Why?
|
| Cardiac Catheterization | 7 | 2024 | 302 | 1.450 |
Why?
|
| Thrombosis | 2 | 2021 | 302 | 1.220 |
Why?
|
| Pulmonary Wedge Pressure | 7 | 2024 | 113 | 1.220 |
Why?
|
| Intra-Aortic Balloon Pumping | 6 | 2022 | 78 | 1.120 |
Why?
|
| Humans | 62 | 2024 | 89063 | 0.990 |
Why?
|
| Cardiac Output | 6 | 2023 | 156 | 0.920 |
Why?
|
| Heart Valve Prosthesis | 1 | 2023 | 97 | 0.860 |
Why?
|
| Aortic Valve | 5 | 2023 | 243 | 0.840 |
Why?
|
| Heart Valve Diseases | 1 | 2023 | 115 | 0.820 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2021 | 136 | 0.780 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2020 | 21 | 0.720 |
Why?
|
| Myocardial Infarction | 1 | 2023 | 373 | 0.720 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2022 | 181 | 0.710 |
Why?
|
| Thrombocytopenia | 1 | 2021 | 187 | 0.710 |
Why?
|
| Tachycardia, Ventricular | 1 | 2020 | 124 | 0.680 |
Why?
|
| Coronary Artery Disease | 2 | 2016 | 362 | 0.680 |
Why?
|
| Prosthesis Implantation | 1 | 2020 | 126 | 0.650 |
Why?
|
| Palliative Care | 1 | 2020 | 263 | 0.630 |
Why?
|
| Prognosis | 8 | 2024 | 3773 | 0.620 |
Why?
|
| Catheter Ablation | 1 | 2020 | 252 | 0.610 |
Why?
|
| Middle Aged | 21 | 2024 | 25863 | 0.610 |
Why?
|
| Stroke Volume | 2 | 2021 | 462 | 0.580 |
Why?
|
| Male | 26 | 2024 | 42251 | 0.550 |
Why?
|
| Hepatitis C, Chronic | 1 | 2017 | 91 | 0.550 |
Why?
|
| Retrospective Studies | 16 | 2024 | 9003 | 0.520 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2015 | 10 | 0.510 |
Why?
|
| Tissue Donors | 2 | 2023 | 490 | 0.500 |
Why?
|
| Spinal Cord Stimulation | 1 | 2015 | 15 | 0.500 |
Why?
|
| Troponin T | 1 | 2015 | 39 | 0.490 |
Why?
|
| Acute Coronary Syndrome | 1 | 2015 | 30 | 0.490 |
Why?
|
| Coronary Artery Bypass | 1 | 2016 | 234 | 0.470 |
Why?
|
| Myocardial Contraction | 1 | 2015 | 252 | 0.460 |
Why?
|
| Predictive Value of Tests | 6 | 2024 | 1715 | 0.460 |
Why?
|
| Cardiotonic Agents | 2 | 2024 | 89 | 0.440 |
Why?
|
| Female | 23 | 2024 | 46011 | 0.430 |
Why?
|
| Aged | 12 | 2024 | 19077 | 0.420 |
Why?
|
| Blood Platelets | 1 | 2012 | 150 | 0.400 |
Why?
|
| Intensive Care Units | 1 | 2015 | 395 | 0.390 |
Why?
|
| Aspirin | 1 | 2012 | 159 | 0.380 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2016 | 516 | 0.380 |
Why?
|
| Hypertension, Pulmonary | 1 | 2015 | 352 | 0.380 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2012 | 143 | 0.380 |
Why?
|
| Prosthesis Design | 3 | 2023 | 296 | 0.370 |
Why?
|
| Sex Factors | 2 | 2023 | 1063 | 0.350 |
Why?
|
| Liver Transplantation | 1 | 2017 | 1177 | 0.340 |
Why?
|
| Cardiac Resynchronization Therapy | 2 | 2021 | 68 | 0.330 |
Why?
|
| Cannula | 2 | 2019 | 50 | 0.300 |
Why?
|
| Adult | 9 | 2024 | 26507 | 0.290 |
Why?
|
| Treatment Outcome | 10 | 2023 | 8203 | 0.290 |
Why?
|
| Prosthesis Failure | 2 | 2017 | 116 | 0.270 |
Why?
|
| Prospective Studies | 6 | 2021 | 4273 | 0.250 |
Why?
|
| Echocardiography | 3 | 2020 | 937 | 0.240 |
Why?
|
| Risk Assessment | 5 | 2024 | 2290 | 0.230 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2023 | 14 | 0.230 |
Why?
|
| Quality of Life | 3 | 2021 | 1662 | 0.230 |
Why?
|
| Atrioventricular Block | 1 | 2023 | 24 | 0.220 |
Why?
|
| Postoperative Complications | 4 | 2022 | 2275 | 0.220 |
Why?
|
| Heart | 2 | 2024 | 573 | 0.220 |
Why?
|
| Reference Standards | 1 | 2023 | 144 | 0.220 |
Why?
|
| Aorta | 2 | 2021 | 288 | 0.210 |
Why?
|
| Thorax | 1 | 2023 | 77 | 0.210 |
Why?
|
| Atrial Pressure | 1 | 2021 | 6 | 0.200 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2023 | 113 | 0.200 |
Why?
|
| Waiting Lists | 1 | 2023 | 183 | 0.200 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2023 | 178 | 0.200 |
Why?
|
| Hydrodynamics | 1 | 2021 | 19 | 0.200 |
Why?
|
| Plasmapheresis | 1 | 2021 | 25 | 0.190 |
Why?
|
| Aortic Rupture | 1 | 2022 | 57 | 0.190 |
Why?
|
| Epoprostenol | 1 | 2021 | 46 | 0.190 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2021 | 25 | 0.190 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2022 | 94 | 0.190 |
Why?
|
| Torsion, Mechanical | 1 | 2020 | 6 | 0.180 |
Why?
|
| Heparin | 1 | 2021 | 185 | 0.180 |
Why?
|
| Counterpulsation | 1 | 2020 | 21 | 0.180 |
Why?
|
| Exercise Test | 1 | 2021 | 165 | 0.180 |
Why?
|
| Oxygen Consumption | 1 | 2021 | 243 | 0.180 |
Why?
|
| Blood Pressure | 1 | 2024 | 899 | 0.180 |
Why?
|
| Exercise Tolerance | 1 | 2020 | 53 | 0.180 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2020 | 55 | 0.180 |
Why?
|
| Health Literacy | 1 | 2021 | 72 | 0.170 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 75 | 0.170 |
Why?
|
| Registries | 1 | 2024 | 778 | 0.170 |
Why?
|
| Tissue and Organ Procurement | 1 | 2024 | 345 | 0.170 |
Why?
|
| Systole | 1 | 2019 | 115 | 0.160 |
Why?
|
| Pulmonary Artery | 1 | 2021 | 319 | 0.160 |
Why?
|
| Myocardium | 1 | 2022 | 571 | 0.160 |
Why?
|
| Muscle Contraction | 1 | 2019 | 284 | 0.150 |
Why?
|
| Anticoagulants | 1 | 2021 | 426 | 0.150 |
Why?
|
| Reoperation | 1 | 2020 | 598 | 0.150 |
Why?
|
| Thermodilution | 1 | 2017 | 21 | 0.150 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 264 | 0.150 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 233 | 0.150 |
Why?
|
| Computer Simulation | 1 | 2021 | 1097 | 0.140 |
Why?
|
| Equipment Safety | 1 | 2016 | 33 | 0.140 |
Why?
|
| Equipment Failure | 1 | 2016 | 121 | 0.130 |
Why?
|
| Baroreflex | 1 | 2015 | 8 | 0.130 |
Why?
|
| Carotid Sinus | 1 | 2015 | 20 | 0.130 |
Why?
|
| Atrial Septum | 1 | 2015 | 9 | 0.130 |
Why?
|
| Risk Factors | 4 | 2024 | 5466 | 0.130 |
Why?
|
| Blood Flow Velocity | 1 | 2015 | 198 | 0.130 |
Why?
|
| Clinical Chemistry Tests | 1 | 2015 | 11 | 0.130 |
Why?
|
| Equipment and Supplies | 1 | 2015 | 28 | 0.130 |
Why?
|
| Cause of Death | 1 | 2016 | 266 | 0.120 |
Why?
|
| Equipment Design | 1 | 2016 | 415 | 0.120 |
Why?
|
| Reference Values | 1 | 2016 | 661 | 0.120 |
Why?
|
| Biological Assay | 1 | 2015 | 79 | 0.120 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 3657 | 0.120 |
Why?
|
| Electric Stimulation Therapy | 1 | 2015 | 46 | 0.120 |
Why?
|
| United States | 6 | 2024 | 6955 | 0.120 |
Why?
|
| Observer Variation | 1 | 2016 | 610 | 0.120 |
Why?
|
| Stroke | 2 | 2020 | 982 | 0.120 |
Why?
|
| Cohort Studies | 2 | 2022 | 2863 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1837 | 0.110 |
Why?
|
| Patient Selection | 2 | 2020 | 682 | 0.110 |
Why?
|
| Acute Disease | 1 | 2015 | 841 | 0.110 |
Why?
|
| Endovascular Procedures | 1 | 2017 | 270 | 0.110 |
Why?
|
| Platelet Function Tests | 1 | 2012 | 11 | 0.100 |
Why?
|
| Platelet Aggregation | 1 | 2012 | 44 | 0.100 |
Why?
|
| Survival Rate | 1 | 2016 | 1889 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 975 | 0.100 |
Why?
|
| Drug Resistance | 1 | 2012 | 232 | 0.100 |
Why?
|
| Treatment Failure | 1 | 2012 | 287 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2752 | 0.080 |
Why?
|
| Time Factors | 3 | 2024 | 5320 | 0.080 |
Why?
|
| Biomarkers | 1 | 2015 | 1755 | 0.080 |
Why?
|
| alpha-Defensins | 1 | 2007 | 2 | 0.070 |
Why?
|
| Respiratory Mucosa | 1 | 2007 | 88 | 0.070 |
Why?
|
| Immunity | 1 | 2007 | 141 | 0.070 |
Why?
|
| Clinical Laboratory Services | 1 | 2024 | 4 | 0.060 |
Why?
|
| Bilirubin | 1 | 2024 | 129 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2007 | 443 | 0.060 |
Why?
|
| Health Care Rationing | 1 | 2024 | 83 | 0.060 |
Why?
|
| Postoperative Care | 1 | 2024 | 229 | 0.050 |
Why?
|
| Tricuspid Valve | 1 | 2023 | 97 | 0.050 |
Why?
|
| Preoperative Care | 1 | 2024 | 396 | 0.050 |
Why?
|
| Propensity Score | 1 | 2022 | 147 | 0.050 |
Why?
|
| Ventricular Pressure | 1 | 2021 | 37 | 0.050 |
Why?
|
| Axillary Artery | 1 | 2020 | 10 | 0.050 |
Why?
|
| Trauma Severity Indices | 1 | 2020 | 44 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2021 | 389 | 0.040 |
Why?
|
| Lung | 1 | 2007 | 1258 | 0.040 |
Why?
|
| Hemodynamic Monitoring | 1 | 2019 | 8 | 0.040 |
Why?
|
| Materials Testing | 1 | 2019 | 93 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2021 | 386 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 299 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2020 | 292 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 848 | 0.040 |
Why?
|
| Motivation | 1 | 2021 | 296 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2020 | 779 | 0.040 |
Why?
|
| Incidence | 1 | 2021 | 1592 | 0.040 |
Why?
|
| Patient Readmission | 1 | 2020 | 351 | 0.040 |
Why?
|
| Obesity | 1 | 2023 | 966 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 1488 | 0.030 |
Why?
|
| Animals | 1 | 2015 | 27317 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 3717 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2007 | 54 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2007 | 86 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2007 | 103 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2007 | 251 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2007 | 91 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2007 | 426 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2007 | 451 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 412 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2007 | 465 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 1940 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2007 | 688 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 2880 | 0.010 |
Why?
|